C-reactive protein: risk marker or mediator in atherothrombosis
Although the hamster model does not fully capture the clinical heterogeneity of human PCS, it enables precise investigation of tissue-specific immunometabolic recovery trajectories following SARS-CoV-2 infection experimentally in a short period of time ( Figures 1 4 )
In research, BPC-157 is thought to act mainly at the site of injury
In honor of World Breastfeeding Week, THRiVE and MILC teamed up with the r/AskScience, forum on Reddit to host an Ask Me Anything (AMA) session with lactation researchers hailing from the fields of biochemistry, epidemiology, microbiology, neonatology, family medicine, nursing, epigenetics, and biological anthropology
Professional Administration: Injections should be administered by a healthcare professional to ensure correct dosing and to minimize risks